Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biodesix Inc - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
BDSX
Nasdaq
8071
https://www.biodesix.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biodesix Inc
Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price
- May 11th, 2024 12:18 pm
Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript
- May 10th, 2024 9:59 pm
Biodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
- May 10th, 2024 7:55 pm
Biodesix First Quarter 2024 Earnings: Beats Expectations
- May 10th, 2024 10:22 am
Biodesix Inc (BDSX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
- May 9th, 2024 7:46 am
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates
- May 8th, 2024 9:20 pm
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
- May 8th, 2024 8:01 pm
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
- May 7th, 2024 10:00 am
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
- Apr 24th, 2024 10:00 am
The recent US$4.0m market cap decrease is likely to have disappointed insiders invested in Biodesix, Inc. (NASDAQ:BDSX)
- Apr 13th, 2024 12:50 pm
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
- Apr 9th, 2024 9:00 pm
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
- Apr 5th, 2024 11:17 am
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
- Mar 25th, 2024 10:00 am
Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript
- Mar 4th, 2024 2:04 pm
Biodesix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
- Mar 3rd, 2024 12:56 pm
Q4 2023 Biodesix Inc Earnings Call
- Mar 2nd, 2024 3:40 am
Biodesix Inc (BDSX) Reports Strong Growth in Lung Diagnostic Test Volume and Gross Profit Margin
- Mar 1st, 2024 11:31 am
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
- Mar 1st, 2024 11:00 am
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
- Feb 26th, 2024 11:00 am
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
- Feb 16th, 2024 11:00 am
Scroll